CSIMarket
 
Akcea Therapeutics Inc   (NASDAQ: AKCA)
 

Akcea Therapeutics Inc's Customers Performance

AKCA



 
AKCA's Source of Revenues During the corresponding time, Akcea Therapeutics Inc saw a revenue deteriorated by -15.95 % year on year, sequentially revenue grew by 39.21 %. While revenue at the Akcea Therapeutics Inc 's corporate clients

• List of AKCA Customers




for the same period Akcea Therapeutics Inc revnue deteriorated by -15.95 % year on year, sequentially revenue grew by 39.21 %.

• List of AKCA Customers

Akcea Therapeutics Inc's Business Units






Akcea Therapeutics Inc's Comment on Sales, Marketing and Customers
















AKCA's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Akcea Therapeutics Inc 0.00 336.56 -41.52 207
SUBTOTAL 0.00 0.00 0.00 -

Sources: Akcea Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Akcea Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Akcea Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.